E
Aclarion, Inc. ACON
$0.685 -$0.1299-15.94%
Recommendation
Sell
Prev Close
$0.8149
Volume
45,629
Avg Vol (90D)
2,539,413
Market Cap
$827.85K
Dividend & Yield
--
52-Week Range
$0.7971 - $231.15
P/E (TTM)
--
EPS (TTM)
-$247.10
My Lists My Alerts
Rating
Reward
E
Very Weak
Risk
E+
Very Weak
Rating Factors
Growth Index
Weak
Efficiency Index
Very Weak
Solvency Index
Good
Total Return Index
Very Weak
Volatility Index
Very Weak
Dividend Index
--
Headlines
Aclarion Provides Shareholder Update
3/13/2025 - GuruFocus
Aclarion Provides Shareholder Update
3/13/2025 - Globe Newswire
Aclarion announces expansion plans with RadNet affiliates in NY, NJ
3/6/2025 - Seeking Alpha - Healthcare
Aclarion Announces Expansion Plans with RadNet Affiliates in New York and New Jersey
3/6/2025 - GuruFocus
Aclarion announces expansion plans with RadNet affiliates in NY, NJ
3/6/2025 - TipRanks Financial Blog
Aclarion Inc trading resumes
3/6/2025 - The Fly
Aclarion announces expansion plans with RadNet affiliates in NY, NJ
3/6/2025 - The Fly
Aclarion Announces Expansion Plans with RadNet Affiliates in New York and New Jersey
3/6/2025 - Globe Newswire
Aclarion Inc trading halted, volatility trading pause
3/6/2025 - The Fly
Is Aclarion's Tie-Up With Scripps Health A Lasting Catalyst? Most Retail Traders Think It's A 'Game-Changer'
3/4/2025 - Stocktwits News Feed
Why Aclarion (ACON) Shares Are Skyrocketing
3/3/2025 - Benzinga
Why Is Healthcare Technology Company Aclarion Stock Rocketing Premarket On Monday?
3/3/2025 - Yahoo! Finance: News
Aclarion announces first commercial agreement with Scripps Health in San Diego
3/3/2025 - The Fly
Aclarion Announces First Commercial Agreement with Scripps Health
3/3/2025 - GuruFocus
Aclarion Announces First Commercial Agreement with Scripps Health
3/3/2025 - Globe Newswire
Aclarion, Inc. Announces Adjournment of Special Meeting of Stockholders
2/28/2025 - GuruFocus
Aclarion, Inc. Announces Adjournment of Special Meeting of Stockholders
2/28/2025 - Globe Newswire
Aclarion, Inc. (ACON) to Showcase NOCISCAN's Impact on Spine Surgery at 2025 Spine Summit
2/20/2025 - Insider Monkey
Aclarion to Showcase Groundbreaking NOCISCAN Technology at the 2025 Spine Summit
2/20/2025 - GuruFocus
Aclarion to Showcase Groundbreaking NOCISCAN Technology at the 2025 Spine Summit
2/20/2025 - Globe Newswire
Aclarion receives U.S. patent on expanded applications of MRS data processing
2/11/2025 - Seeking Alpha - Healthcare
Aclarion receives U.S. patent on expanded applications of MRS data processing
2/11/2025 - The Fly
Aclarion Receives US Patent to Protect Expanded Applications of Magnetic Resonance Spectroscopy ...
2/11/2025 - GuruFocus
Aclarion Receives US Patent to Protect Expanded Applications of Magnetic Resonance Spectroscopy (MRS) Data Processing to Identify Pain and Infection Biomarkers Throughout the Body
2/11/2025 - Globe Newswire
Aclarion Announces Northwestern Medicine as First CLARITY Trial Site
2/6/2025 - GuruFocus
Income Statement
Total Revenue (TTM)
$49.30K
EBITDA (TTM)
-$4.65M
EBIT (TTM)
-$4.83M
Net Income (TTM)
-$6.27M
Balance Sheet
Total Assets (Q)
$3.19M
Total Debt (Q)
$0.00
Total Liabilities (Q)
$678.30K
Book Value Per Share (Q)
$83.70
Cash Flow
Cash from Operations (TTM)
-$5.08M
Cash from Investing (TTM)
-$295.20K
Cash from Financing (TTM)
$6.53M
Net Change in Cash (TTM)
$1.15M
Filings
Filing Date
Thursday, November 14, 2024
Period Date
Monday, September 30, 2024
Next Filing
Week of Feb 17 and 21 (est)
Price History
Loading...
Beta
0.77
7-Day Total Return
-88.09%
30-Day Total Return
-92.56%
60-Day Total Return
-98.21%
90-Day Total Return
-98.97%
Year to Date Total Return
-98.56%
1-Year Total Return
-99.43%
2-Year Total Return
-99.98%
3-Year Total Return
--
5-Year Total Return
--
52-week Low
Mar 12, 2025 - $0.7971
52-week High
Apr 25, 2024 - $231.15
Valuation
Market Cap
$827.85K - Nano Cap
Enterprise Value
-$534.25K
Price/Sales (TTM)
0.47
Price/Book (Q)
0.01
Dividends and Shares
Shares Outstanding
28.20K
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.aclarion.com
Phone Number
833 275 2266
Address
8181 Arista Place
Broomfield, CO 80021
Country
United States
Year Founded
2008
Business Description
Sector
Health Care
Industry
Health Care Equipment and Services
Aclarion, Inc. operates as a healthcare technology company in the United States. The company uses magnetic resonance spectroscopy (MRS) and proprietary biomarkers to optimize clinical treatments... more
NASDAQ 03/13/2025 4:00PM Eastern Quotes delayed
Weiss Ratings